On ECHEMI
Home > Drugs > Esophageal cancer in the elderly
Esophageal cancer in the elderly
Esophageal cancer is a malignant tumor that originates mainly from the squamous and columnar epithelium of the esophagus, with squamous cell carcinoma accounting for about 90% and adenocarcinoma accounting for about 10%. The most typical clinical manifestation of esophageal cancer is progressive dysphagia.
  • Site of disease:

    esophagus
  • Infectious :

    Not contagious
  • Frequent population:

    Low immunity, long-term smoking and drinking, elderly...
  • Related symptoms:

    Frequent mucus vomiting difficulty swallowing pain behind the sternum gastroesophageal reflux symptoms persistent pain
  • Concurrent disease:

Related Drugs
Paclitaxel Injection
Indication: First-line chemotherapy for metastatic ovarian cancer after initial or subsequent chemotherapy failure. Metastatic breast cancer after combined chemotherapy failure or recurrence within 6 months of adjuvant chemotherapy, first-line treatment for advanced non-small cell lung cancer, and adjuvant therapy after surgery for lymph node-positive breast cancer.
Manufacturer:

Haikou Pharmaceutical Factory Co., Ltd.

Paclitaxel Injection
Indication: First-line chemotherapy for metastatic ovarian cancer after initial or subsequent chemotherapy failure. Metastatic breast cancer after combined chemotherapy failure or recurrence within 6 months of adjuvant chemotherapy, first-line treatment for advanced non-small cell lung cancer, and adjuvant therapy after surgery for lymph node-positive breast cancer.
Manufacturer:

Haikou Pharmaceutical Factory Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.